Back

VJHemOnc is committed to improving our service to you

iwNHL 2018 | Viral lymphomas: risk factors and treatments

VJHemOnc is committed to improving our service to you

Catherine Bollard, Mark Roschewski, Richard Little and Ruth Jarrett

Viruses such Epstein-Barr virus (EBV) and HIV have been aetiologically linked to a significant number of lymphoproliferative diseases. In this roundtable discussion, lead by Catherine Bollard, MBChB, MD, FRACP, FRCPA, of the Children’s National Health System, Washington, DC, Dr Bollard covers the risk factors for viral lymphomas, as well as the current landscape for therapy and trial participation. She is joined by Ruth Jarrett, MD, PhD, from the University of Glasgow Center for Virus Research, Glasgow, UK, Mark Roschewski, MD, of the National Cancer Institute, Bethesda, MD, and Richard Little, MD, of the National Cancer Institute, Rockville, MD, at the International Workshop on Non-Hodgkin Lymphoma (iwNHL) 2018 meeting, held in Nice, France.

Share this video  

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter